Urologische Praxis
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Werner, Thorsten
PREPARE, NCT03013946 / 2016-000399-28: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy

Terminated
3
121
Europe
Concomitant coaching
AIO-Studien-gGmbH, Pfizer, Crolll Gmbh
Renal Cell Carcinoma, Metastatic, Renal Cell Cancer, Recurrent
01/24
01/24
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
PROCARE, NCT06835218: - PROstate Cancer Real World Evidence Registry

Recruiting
N/A
5000
Europe
UroTrials Company (GmbH), Novartis Pharmaceuticals, AstraZeneca
Prostate Cancer, Biochemical Recurrence of Malignant Neoplasm of Prostate, Non-metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Metastatic Castration-resistant Prostate Cancer
03/31
12/32
Herz, Andreas
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
Hess, Jochen
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
Farid, Arian
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Werner, Thorsten
PREPARE, NCT03013946 / 2016-000399-28: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy

Terminated
3
121
Europe
Concomitant coaching
AIO-Studien-gGmbH, Pfizer, Crolll Gmbh
Renal Cell Carcinoma, Metastatic, Renal Cell Cancer, Recurrent
01/24
01/24
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
PROCARE, NCT06835218: - PROstate Cancer Real World Evidence Registry

Recruiting
N/A
5000
Europe
UroTrials Company (GmbH), Novartis Pharmaceuticals, AstraZeneca
Prostate Cancer, Biochemical Recurrence of Malignant Neoplasm of Prostate, Non-metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer (mHSPC), Metastatic Castration-resistant Prostate Cancer
03/31
12/32
Herz, Andreas
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
Hess, Jochen
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28
Farid, Arian
NCT02106572 / 2013-003446-16: Therapeutic Instillation of Mistletoe

Recruiting
3
548
Europe, RoW
abnobaVISCUM 900, viscum album extract, mistletoe extract, abnobaVISCUM, Mitomycin C, MMC, Mitomycin
Abnoba Gmbh
Superficial Bladder Cancer
06/28
12/28

Download Options